TCL Archive In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements February 19, 1988
TCL Archive In Brief: Rogers On AHF Board; GAO Says Legislation May Needed For Hospice Reimbursement March 23, 1979
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
